Grund Nicholas - Insider Non-Derivative Transactions at Akebia Therapeutics, Inc. (AKBA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Feb 3, 2025, Grund Nicholas's relationship to Akebia Therapeutics, Inc. (AKBA) is Officer (Chief Commercial Officer), and currently has 442,579 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AKBA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Grund Nicholas - Insider Non-Derivative Transactions of AKBA Common Stock

Grund Nicholas - Insider Non-Derivative Transactions at AKBA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 4, 2025	Sell -- (Common Stock)	55621	2.1	442579
Feb 1, 2025	Acquisition -- (Common Stock)	194900	0	498200
Feb 1, 2024	Acquisition -- (Common Stock)	303300	0	303300